Fulgent Genetics, Inc. - Officer Stock Transaction

On October 26, 2025, Gao Hanlin, the Chief Scientific Officer of Fulgent Genetics, Inc., disposed of 1,642 shares of common stock at a price of $23.74 per share. This transaction was related to the withholding of shares to satisfy tax obligations arising from the vesting of restricted stock units. Following this transaction, Gao Hanlin owns 955,443 shares of common stock. The restricted stock units were originally reported in a Form 4 filed on November 9, 2022, and were assumed pursuant to a merger agreement dated November 7, 2022.